307 related articles for article (PubMed ID: 35994403)
41. Anticholinergic medications and risk of dementia in older adults: Where are we now?
Chatterjee S; Talwar A; Aparasu RR
Expert Opin Drug Saf; 2020 Oct; 19(10):1251-1267. PubMed ID: 32797761
[TBL] [Abstract][Full Text] [Related]
42. Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life.
Rutjes AW; Denton DA; Di Nisio M; Chong LY; Abraham RP; Al-Assaf AS; Anderson JL; Malik MA; Vernooij RW; Martínez G; Tabet N; McCleery J
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011906. PubMed ID: 30556597
[TBL] [Abstract][Full Text] [Related]
43. Long-term neurocognitive and other side effects of radiotherapy, with or without chemotherapy, for glioma.
Lawrie TA; Gillespie D; Dowswell T; Evans J; Erridge S; Vale L; Kernohan A; Grant R
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD013047. PubMed ID: 31425631
[TBL] [Abstract][Full Text] [Related]
44. Impact of Multiple Prescriptions With Anticholinergic Properties on Adverse Clinical Outcomes in the Elderly: A Longitudinal Cohort Study in Taiwan.
Hsu WH; Huang ST; Lu WH; Wen YW; Chen LK; Hsiao FY
Clin Pharmacol Ther; 2021 Oct; 110(4):966-974. PubMed ID: 33626177
[TBL] [Abstract][Full Text] [Related]
45. Anticholinergic Medication Burden and 5-Year Risk of Hospitalization and Death in Nursing Home Elderly Residents With Coronary Artery Disease.
Vetrano DL; La Carpia D; Grande G; Casucci P; Bacelli T; Bernabei R; Onder G;
J Am Med Dir Assoc; 2016 Nov; 17(11):1056-1059. PubMed ID: 27590402
[TBL] [Abstract][Full Text] [Related]
46. Anticholinergic exposure and cognitive decline in older adults: effect of anticholinergic exposure definitions in a 3-year analysis of the multidomain Alzheimer preventive trial (MAPT) study.
Andre L; Gallini A; Montastruc F; Coley N; Montastruc JL; Vellas B; Andrieu S; Gardette V;
Br J Clin Pharmacol; 2019 Jan; 85(1):71-99. PubMed ID: 30098049
[TBL] [Abstract][Full Text] [Related]
47. A Cohort Study of Anticholinergic Medication Burden and Incident Dementia and Stroke in Older Adults.
Lockery JE; Broder JC; Ryan J; Stewart AC; Woods RL; Chong TT; Cloud GC; Murray A; Rigby JD; Shah R; Storey E; Ward SA; Wolfe R; Reid CM; Collyer TA; Ernst ME;
J Gen Intern Med; 2021 Jun; 36(6):1629-1637. PubMed ID: 33754317
[TBL] [Abstract][Full Text] [Related]
48. The excess mortality risk associated with anticholinergic burden among older patients discharged from acute care hospital with depressive symptoms.
Corsonello A; Cozza A; D'Alia S; Onder G; Volpato S; Ruggiero C; Cherubini A; Di Rosa M; Fabbietti P; Lattanzio F
Eur J Intern Med; 2019 Mar; 61():69-74. PubMed ID: 30449478
[TBL] [Abstract][Full Text] [Related]
49. Withdrawal of antihypertensive drugs in older people.
Reeve E; Jordan V; Thompson W; Sawan M; Todd A; Gammie TM; Hopper I; Hilmer SN; Gnjidic D
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD012572. PubMed ID: 32519776
[TBL] [Abstract][Full Text] [Related]
50. Association between anticholinergic (atropinic) drug exposure and cognitive function in longitudinal studies among individuals over 50 years old: a systematic review.
Andre L; Gallini A; Montastruc F; Montastruc JL; Piau A; Lapeyre-Mestre M; Gardette V
Eur J Clin Pharmacol; 2019 Dec; 75(12):1631-1644. PubMed ID: 31468067
[TBL] [Abstract][Full Text] [Related]
51. Anticholinergic drugs and functional, cognitive impairment and behavioral disturbances in patients from a memory clinic with subjective cognitive decline or neurocognitive disorders.
Dauphinot V; Mouchoux C; Veillard S; Delphin-Combe F; Krolak-Salmon P
Alzheimers Res Ther; 2017 Aug; 9(1):58. PubMed ID: 28764796
[TBL] [Abstract][Full Text] [Related]
52. Interventions for improving medication-taking ability and adherence in older adults prescribed multiple medications.
Cross AJ; Elliott RA; Petrie K; Kuruvilla L; George J
Cochrane Database Syst Rev; 2020 May; 5(5):CD012419. PubMed ID: 32383493
[TBL] [Abstract][Full Text] [Related]
53. Anticholinergics Influence Transition from Normal Cognition to Mild Cognitive Impairment in Older Adults in Primary Care.
Campbell NL; Lane KA; Gao S; Boustani MA; Unverzagt F
Pharmacotherapy; 2018 May; 38(5):511-519. PubMed ID: 29600808
[TBL] [Abstract][Full Text] [Related]
54. Computerised cognitive training for preventing dementia in people with mild cognitive impairment.
Gates NJ; Vernooij RW; Di Nisio M; Karim S; March E; Martínez G; Rutjes AW
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012279. PubMed ID: 30864747
[TBL] [Abstract][Full Text] [Related]
55. Algorithm-based pain management for people with dementia in nursing homes.
Manietta C; Labonté V; Thiesemann R; Sirsch EG; Möhler R
Cochrane Database Syst Rev; 2022 Apr; 4(4):CD013339. PubMed ID: 35363380
[TBL] [Abstract][Full Text] [Related]
56. Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Ritchie C; Smailagic N; Noel-Storr AH; Takwoingi Y; Flicker L; Mason SE; McShane R
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD008782. PubMed ID: 24913723
[TBL] [Abstract][Full Text] [Related]
57. Palliative care interventions in advanced dementia.
Murphy E; Froggatt K; Connolly S; O'Shea E; Sampson EL; Casey D; Devane D
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD011513. PubMed ID: 27911489
[TBL] [Abstract][Full Text] [Related]
58. Interventions for preventing and reducing the use of physical restraints for older people in all long-term care settings.
Möhler R; Richter T; Köpke S; Meyer G
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD007546. PubMed ID: 37500094
[TBL] [Abstract][Full Text] [Related]
59. Anticholinergic Burden and Functional Status in Older People with Cognitive Impairment: Results from the Regal Project.
Boccardi V; Baroni M; Paolacci L; Ercolani S; Longo A; Giordano M; Ruggiero C; Mecocci P
J Nutr Health Aging; 2017; 21(4):389-396. PubMed ID: 28346565
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
